Clinical trials
Biliary Tract Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
151 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2012 | 4 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 14 |
| 2021 | 11 |
| 2022 | 13 |
| 2023 | 10 |
| 2024 | 21 |
| 2025 | 21 |
| 2026 | 26 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 54 |
| Unknown status | 42 |
| Completed | 28 |
| Active, not recruiting | 14 |
| Not yet recruiting | 11 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 14 |
| AstraZeneca | 10 |
| Shanghai Zhongshan Hospital | 9 |
| Fudan University | 7 |
| Sun Yat-sen University | 6 |
| Tianjin Medical University Cancer Institute and Hospital | 5 |
| Peking University | 4 |
| West China Hospital | 4 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 3 |
| Chinese PLA General Hospital | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 151 |
| Cholangiocarcinoma | 23 |
| Gallbladder Neoplasms | 21 |
| Stomach Neoplasms | 15 |
| Pancreatic Neoplasms | 12 |
| Colorectal Neoplasms | 10 |
| Bile Duct Neoplasms | 7 |
| Liver Neoplasms | 7 |
| Breast Neoplasms | 6 |
| Carcinoma, Hepatocellular | 6 |
Trials
Showing 26 to 50 of 151. Each trial links to its page on Pharma Observatory.
51 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.